Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Waterboer

Showing results (321-330 of 431) with videos related to

Pageof 44
Sort By:
Human Vaccines & Immunotherapeutics|December 9, 2014
Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assayHilary A Robbins, Tim Waterboer, Carolina Porras, et al.
Cancer Research|September 20, 2012
Biomarkers of HPV in head and neck squamous cell carcinomaCaihua Liang, Carmen J Marsit, Michael D McClean, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 31, 2024
Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 YearsGypsyamber D'Souza, Sakshi R Tewari, Tanya Troy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 12, 2013
Human papillomavirus load in eyebrow hair follicles and risk of cutaneous squamous cell carcinomaRachel E Neale, Soenke Weissenborn, Damiano Abeni, et al.
Vaccine|July 28, 2020
Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccinesSabrina H Tsang, Partha Basu, Noemi Bender, et al.
Clinical Epigenetics|July 1, 2020
Identifying epigenetic biomarkers of established prognostic factors and survival in a clinical cohort of individuals with oropharyngeal cancerRyan Langdon, Rebecca Richmond, Hannah R Elliott, et al.
Brain : a Journal of Neurology|November 6, 2023
Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosisViktor Grut, Martin Biström, Jonatan Salzer, et al.
European Urology Oncology|November 10, 2023
Penile Cancers Attributed to Human Papillomavirus Are Associated with Improved Survival for Node-positive Patients. Findings from a Norwegian Cohort Study Spanning 50 YearsChristian A Moen, Thea E Falkenthal, Tor K Thorkelsen, et al.
The Lancet. Infectious Diseases|July 10, 2018
Advancing the public health applications of Chlamydia trachomatis serologySarah C Woodhall, Rachel J Gorwitz, Stephanie J Migchelsen, et al.
Vaccine|March 20, 2018
Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian studyRengaswamy Sankaranarayanan, Smita Joshi, Richard Muwonge, et al.
Pageof 44

Showing results (321-330 of 431) with videos related to

Sort By:
Pageof 44
Human Vaccines & Immunotherapeutics|December 9, 2014
Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assayHilary A Robbins, Tim Waterboer, Carolina Porras, et al.
Cancer Research|September 20, 2012
Biomarkers of HPV in head and neck squamous cell carcinomaCaihua Liang, Carmen J Marsit, Michael D McClean, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 31, 2024
Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 YearsGypsyamber D'Souza, Sakshi R Tewari, Tanya Troy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 12, 2013
Human papillomavirus load in eyebrow hair follicles and risk of cutaneous squamous cell carcinomaRachel E Neale, Soenke Weissenborn, Damiano Abeni, et al.
Vaccine|July 28, 2020
Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccinesSabrina H Tsang, Partha Basu, Noemi Bender, et al.
Clinical Epigenetics|July 1, 2020
Identifying epigenetic biomarkers of established prognostic factors and survival in a clinical cohort of individuals with oropharyngeal cancerRyan Langdon, Rebecca Richmond, Hannah R Elliott, et al.
Brain : a Journal of Neurology|November 6, 2023
Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosisViktor Grut, Martin Biström, Jonatan Salzer, et al.
European Urology Oncology|November 10, 2023
Penile Cancers Attributed to Human Papillomavirus Are Associated with Improved Survival for Node-positive Patients. Findings from a Norwegian Cohort Study Spanning 50 YearsChristian A Moen, Thea E Falkenthal, Tor K Thorkelsen, et al.
The Lancet. Infectious Diseases|July 10, 2018
Advancing the public health applications of Chlamydia trachomatis serologySarah C Woodhall, Rachel J Gorwitz, Stephanie J Migchelsen, et al.
Vaccine|March 20, 2018
Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian studyRengaswamy Sankaranarayanan, Smita Joshi, Richard Muwonge, et al.
Pageof 44